Cetirizine orally disintegrating

Drug Profile

Cetirizine orally disintegrating

Alternative Names: AdvaTab® Cetirizine; EUR 1010-D

Latest Information Update: 06 May 2011

Price : $50

At a glance

  • Originator Eurand
  • Developer Adare Pharmaceuticals
  • Class Acetic acids; Antiallergics; Nonsedating antihistamines; Piperazines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Hypersensitivity

Most Recent Events

  • 11 Feb 2011 Eurand has been acquired and merged into Axcan Pharma
  • 19 Aug 2009 Suspended - Phase-I for Allergy in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top